This is a routine, low-ratio sell-to-cover transaction tied to vesting RSUs, not a discretionary market sale. It should have no material price impact. Monitor upcoming Form 4 filings to confirm actual execution; if volumes far exceed the stated 3,054 shares, that would be a deviation from this notice.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 5 $212.35entry
- T+1 · 5mo ago −1.09%α −1.32% · $210.03
- T+5 · 5mo ago −2.26%α −2.83% · $207.56
- T+20 · 4mo ago +0.44%α −1.42% · $213.28
- T+60 · 3mo ago +9.44%α +5.44% · $232.39
Price Chart
How similar events traded
Executive Summary
Daniel A. Carestio, an officer and director of STERIS plc, filed a Form 144 notice to sell 3,054 ordinary shares currently held via restricted stock units that vested on May 31, 2026. At the filing date, the estimated aggregate market value of the sale is approximately $655,511, based on a valuation of $214.67 per share. This is a pre-scheduled, tax-related insider sale tied to a compensation vesting event, not a discretionary open-market sale.
Key Facts
- Filer: Daniel A. Carestio, identified as both Officer and Director in the filing.
- Security: 3,054 ordinary shares from restricted stock that lapsed/vested on May 31, 2026.
- Estimated market value: $655,511 (based on 06/04/2026 date).
- Shares are to be sold via Charles Schwab & Co., Inc. on NYSE.
- No open-market purchase by the insider contemporaneously; this is a pure sell-to-cover or tax-related disposition.
- Filing date: June 4, 2026.
Financial Impact
Proceeds up to ~$655,511 from sale of 3,054 shares, representing less than 0.01% of $20.5B market cap.
Risk Factors
- insider selling
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001921094-26-000604 |
| Document: 0001921094-26-000604-index.html | 0001921094-26-000604 |
| Document: 0001921094-26-000604.txt | 0001921094-26-000604 |
Track record
21 reports on STE
1 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +17.96% at T+20 after the Oct 13, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 13, 20263d ago 144 Neutral 2/10 Entry $264.32 Now $261.91 −0.91% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $264.32 Now $261.91 −0.91% settles Nov 20
- Nov 12, 20264d ago 8-K Neutral 4/10 Entry $264.32 Now $261.91 −0.91% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $253.44 Now $261.91 +3.34% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $256.27 Now $261.91 +2.20% settles Nov 18
- Nov 4, 202612d ago 8-K Neutral 4/10 Entry $254.12 to $253.44 Now $261.91 +3.07% ▼ −0.27% −3.56% vs SPY
- Nov 4, 202612d ago 8-K Bullish 6/10 No price data
- Nov 4, 202612d ago Press Release Bullish 6/10 Entry $254.12 to $253.44 Now $261.91 +3.07% ▼ −0.27% −3.56% vs SPY
- Oct 28, 202619d ago Press Release Neutral 2/10 Entry $232.14 to $254.12 Now $261.91 +12.82% ▲ +9.47% +14.19% vs SPY
- Oct 20, 202627d ago Press Release Neutral 1/10 Entry $221.48 to $228.49 Now $261.91 +18.25% ▲ +3.17% +3.61% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers